Project Grant 2533720
- This $432,740 Project Grant award from the National Science Foundation's (NSF) Engineering program (CFDA 47.041) to the Cal Poly Corporation supports the development of a new class of paper-based chronometric biosensors. The objective is to create quantitative point-of-care diagnostic tools that can detect a range of biological analytes, including disease markers, environmental contaminants, and security threats, using time as the sensing signal. The novel biosensors will leverage polymer...
- Federal Grant Award Summary The University of Utah's Office of Sponsored Projects received a $523,361 Project Grant from the National Science Foundation (NSF) Directorate for Engineering (CFDA 47.041) awarded March 1, 2026, with completion targeted for February 28, 2029. This award funds development of a bioorthogonal signal transduction system utilizing chemical exponential signal amplification for biosensing and diagnostic applications. The core deliverable is a purely chemical approach to...
- Federal Grant Award Summary The National Science Foundation's Directorate for Engineering (CFDA 47.041) awarded University of California, Irvine $210,000 for an Exploratory research (EAGER) project beginning May 1, 2026 and concluding April 30, 2028. The project develops an Enzymatic Perturbation Specificity Test (EPST), a built-in validation mechanism for wearable and point-of-care biosensors that operate in interstitial fluid beneath the skin. EPST addresses a critical gap in current biosensor...
- Summary of Federal Project Grant Award The National Science Foundation's Directorate for Engineering, Division of Chemical, Bioengineering, Environmental, and Transport Systems (CFDA 47.041) awarded $199,934 to the University of Maryland Eastern Shore (UMES) for the project "Developing an Impedimetric Immunosensor for Characterization of Phagocytosis" effective June 1, 2026 through May 31, 2028. This Early-Career Research (ERI) project will develop a compact, label-free biosensing...
- Federal Project Grant Award Summary Emory University's Office of Sponsored Programs received a $399,930 Project Grant from the National Science Foundation (NSF) Directorate for Engineering (CFDA 47.041) beginning September 1, 2026, and concluding August 31, 2029. The award funds development of a plasmonic biosensing platform that converts optical measurements into direct electrical signals through quantum tunneling processes. Rather than relying on conventional spectrometer-based optical...
- Federal Project Grant Award Summary Award Details: Funding Agency: National Science Foundation (NSF), Division of Chemical, Bioengineering, Environmental, and Transport Systems Federal Grant Program: Engineering (CFDA 47.041) Award Amount: $416,087 Award Date: May 1, 2025 Project Period: May 1, 2025 – April 30, 2028 Primary Awardee: Oregon State University (Corvallis, OR) This collaborative research project delivers fundamental scientific research and development services focused on...
- Federal Project Grant Award Summary Florida International University received a $442,106 Project Grant from the National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems (CFDA 47.041 - Engineering program) effective May 15, 2025, through April 30, 2028. The award funds development of an ultrasensitive, label-free electrical detection method for small molecules using glass nanopipettes, a type of solid-state nanopore biosensor. The research...
- Federal Project Grant Award Summary Boston University received a $450K Project Grant from the National Science Foundation's Division of Chemical, Bioengineering, Environmental, and Transport Systems under the Engineering program (CFDA 47.041) on November 1, 2025, for development and validation of wireless, free-floating biosensors designed for in-situ microbial monitoring within industrial fermentation environments. The award, which extends through October 31, 2027, supports the development of a...
- Federal Project Grant Summary Oregon State University received a $200,000 Project Grant awarded April 1, 2026, through the National Science Foundation's Division of Materials Research under the Mathematical and Physical Sciences program (CFDA 47.049). The three-year collaborative research project, concluding March 31, 2029, focuses on elucidating the structure and function of direct delivery peptides—a novel class of molecules capable of crossing cell membranes with significantly higher...
- This $450,000 Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) to The Johns Hopkins University supports the development of a new "dual-series gate" organic electrochemical transistor (DS-OECT) biosensor technology. The key objectives include material synthesis, device fabrication, computer modeling, and biological fluid analysis to create a highly sensitive and stable sensor capable of reliably detecting protein biomarkers for various...
Summary of Federal Project Grant Award Oregon State University received a $443,904 Project Grant from the National Science Foundation's Directorate for Engineering (CFDA 47.041) awarded July 15, 2026, with completion targeted for June 30, 2029. The project develops a novel biosensing platform based on electrocatalytic surface molecularly imprinted polymers that function as synthetic enzyme mimics for continuous, real-time electrochemical detection of small molecules. The deliverable overcomes critical limitations in existing biosensor technology by replacing fragile biological receptors—such as enzymes and antibodies—with durable, electrically controlled synthetic materials capable of long-term and continuous operation in field and clinical settings outside laboratory environments. The core technical innovation involves ultra-thin polymer sensing layers deposited directly on electrode surfaces and engineered to recognize specific target molecules. These layers incorporate built-in catalysts that drive chemical reactions; upon molecular binding, a small electrical signal triggers a measurable electrochemical response proportional to the number of bound molecules. The platform design enables electrical control of product release and sensor reset, permitting repeated measurements in complex biological fluids. The flexible platform architecture allows adaptation to detect different molecules relevant to human health monitoring, including hormones, metabolites, and therapeutic drugs. Broader impacts include advancing biosensing science through reliable continuous monitoring, supporting interdisciplinary student training, and enabling improved health and environmental sensing applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $443.9k | 7/15/26 |